Jefferies Financial Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,000
Closed -$863K 1855
2025
Q4
$863K Sell
13,000
-150,000
-92% -$9.7M ﹤0.01% 1144
2025
Q3
$11M Buy
163,000
+150,000
+1,154% +$11.9M 0.05% 221
2025
Q2
$1.13M Buy
+13,000
New +$1.02M 0.01% 698

Other funds holding DXCM

Jefferies Financial Group's DXCM Position: Q2 2026 in Review

Jefferies Financial Group increased its DexCom (DXCM) stake by 199% in Q2 2026, buying an estimated $2.72M and bringing the position to 61,434 shares worth $4.14M. The position accounts for 0.03% of the portfolio, ranked #433.

Jefferies Financial Group first reported a position in DXCM in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.97M in Q4 2022. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Jefferies Financial Group held 61,434 shares of DexCom worth $4.14M as of Q2 2026.
  • Jefferies Financial Group bought 40,879 DexCom shares in Q2 2026, an estimated $2.72M.
  • DexCom made up 0.03% of Jefferies Financial Group's portfolio in Q2 2026, its #433 holding.
  • Jefferies Financial Group first reported a position in DexCom in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's DexCom position peaked at $7.97M in Q4 2022.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.